MRNA250117C155000
- 0.02
- 0.000.00%
Moderna Newsroom
RFK Jr. Reportedly Softens His Antivaccine Stance Ahead of Confirmation Hearing
Moderna Stock Rises Following RFK Jr's Comments
Shares of Vaccine Stocks Are Trading Higher. HHS Secretary Nominee Robert F. Kennedy Jr. Reportedly Said He Is Not Anti-vaccine Ahead of Upcoming Confirmation Hearings.
"RFK Jr. Says He's Not Anti-Vaccine, Sees Critical Role for Shots" - Bloomberg News
Goldman Sachs Maintains Moderna(MRNA.US) With Buy Rating, Cuts Target Price to $99
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm?
Moderna (MRNA) Increases Despite Market Slip: Here's What You Need to Know
ETFs Shine As S&P 500 Hits Record High: Top 5 ETFs With Best Gains From Last Week
J.P. Morgan Maintains Moderna(MRNA.US) With Sell Rating, Announces Target Price $40
Moderna Is Maintained at In-Line by Evercore ISI Group
Moderna Analyst Ratings
Evercore Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $50
Goldman Sachs Adjusts Price Target on Moderna to $99 From $112, Keeps Buy Rating
Express News | RPT-Buzz-US Stocks Weekly: Starstruck
Express News | Moderna : JP Morgan Cuts Target Price to $40 From $45
Why Moderna Stock Jumped Over 20% This Week
Stargate Project's Healthcare Winners: AI-led Biotechs and Metagenomi
Four Years After Covid-19 Success, MRNA Vaccines Aren't Ready for Bird Flu -- Barrons.com
S&P 500 Posts Weekly Gain Amid Earnings Beats, Start of Trump Presidency
Moderna Options Spot-On: On January 24th, 212.26K Contracts Were Traded, With 724.8K Open Interest
On January 24th ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 212.26K options for the day, of which put options accounted for 25.54% of the total transactions,